Solid Biosciences Inc. — Director's Dealing 2022

May 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2022-05-02

Reporting Person: Ganot Ilan (Director, CEO & President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-02	Restricted Stock Units	$	A	46600	Acquired		Common Stock (46600)	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuers common stock.

F2: The restricted stock units were granted on May 2, 2022 and vest in two equal annual installments beginning on the first anniversary of the grant date.